Evotec and Immuneering to collaborate on AI driven ligand identification for rare diseases
Evotec announced it has entered into a research collaboration with Immuneering Corp., a worldwide leader in data-driven drug discovery, to discover novel small molecules for rare hereditary metabolic diseases. No financial details of the alliance were disclosed. November 21, 2018